The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
EURAMOS-1 study: Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma.
Jeremy Whelan
No relevant relationships to disclose
Jane Hook
Employment or Leadership Position - MRC-UK
Stefan S. Bielack
No relevant relationships to disclose
Neyssa Marina
No relevant relationships to disclose
Sigbjorn Smeland
No relevant relationships to disclose
Gordana Jovic
Employment or Leadership Position - MRC-UK
Mark D. Krailo
No relevant relationships to disclose
Thomas Kühne
No relevant relationships to disclose
Mikael Eriksson
No relevant relationships to disclose
Trude Butterfass-Bahloul
No relevant relationships to disclose
Lisa A. Teot
No relevant relationships to disclose
Leo Kager
No relevant relationships to disclose
Hans Gelderblom
No relevant relationships to disclose
Kirsten Sundby Hall
No relevant relationships to disclose
Pancras C. W. Hogendoorn
No relevant relationships to disclose
Matthew Robert Sydes
Employment or Leadership Position - MRC-UK
Mark L. Bernstein
No relevant relationships to disclose